DE3876817D1 - Anwendung des humanblut-koagulationsfaktors-xiii zur behandlung von colitis gravis. - Google Patents

Anwendung des humanblut-koagulationsfaktors-xiii zur behandlung von colitis gravis.

Info

Publication number
DE3876817D1
DE3876817D1 DE8888101669T DE3876817T DE3876817D1 DE 3876817 D1 DE3876817 D1 DE 3876817D1 DE 8888101669 T DE8888101669 T DE 8888101669T DE 3876817 T DE3876817 T DE 3876817T DE 3876817 D1 DE3876817 D1 DE 3876817D1
Authority
DE
Germany
Prior art keywords
treatment
factor xiii
blood coagulation
human blood
coagulation factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE8888101669T
Other languages
English (en)
Other versions
DE3876817T2 (de
Inventor
Mikio Urabe
Satoshi Tanaka
Kenichiro Tsumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12192122&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3876817(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Publication of DE3876817D1 publication Critical patent/DE3876817D1/de
Application granted granted Critical
Publication of DE3876817T2 publication Critical patent/DE3876817T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
DE8888101669T 1987-02-09 1988-02-05 Anwendung des humanblut-koagulationsfaktors-xiii zur behandlung von colitis gravis. Revoked DE3876817T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62026387A JPS63196520A (ja) 1987-02-09 1987-02-09 潰瘍性大腸炎治療剤

Publications (2)

Publication Number Publication Date
DE3876817D1 true DE3876817D1 (de) 1993-02-04
DE3876817T2 DE3876817T2 (de) 1993-05-19

Family

ID=12192122

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888101669T Revoked DE3876817T2 (de) 1987-02-09 1988-02-05 Anwendung des humanblut-koagulationsfaktors-xiii zur behandlung von colitis gravis.

Country Status (16)

Country Link
US (1) US5378687A (de)
EP (1) EP0278416B1 (de)
JP (1) JPS63196520A (de)
KR (1) KR960014789B1 (de)
AT (1) ATE83665T1 (de)
AU (1) AU615428B2 (de)
CA (1) CA1322161C (de)
DE (1) DE3876817T2 (de)
DK (1) DK63488A (de)
ES (1) ES2052614T3 (de)
GR (1) GR3007331T3 (de)
HU (1) HU200277B (de)
IE (1) IE61713B1 (de)
IL (1) IL85346A (de)
PT (1) PT86721B (de)
ZA (1) ZA88852B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
JPH03240738A (ja) * 1990-02-20 1991-10-28 Hoechst Japan Ltd 糖尿病性壊疽治療剤
AU3428493A (en) * 1991-12-31 1993-07-28 Zymogenetics Inc. Novel human transglutaminases
ATE171071T1 (de) * 1991-12-31 1998-10-15 Zymogenetics Inc Verfahren und zusammensetzungen zur verminderung von blutverlust
CA2463530A1 (en) 2001-10-09 2003-05-08 Zymogenetics, Inc. Method for inhibiting the formation of seromas using factor xiii
US20060104946A1 (en) * 2002-08-23 2006-05-18 Zymogenetics, Inc. Method for treating inflammatory bowel disease
JP5086093B2 (ja) 2004-11-23 2012-11-28 ジモジェネティクス、インコーポレイテッド 組換え型ヒトｘｉｉｉ因子の精製
US20140286927A1 (en) * 2012-06-19 2014-09-25 Peter Edward Smith Method for the treatment of ulcerative colitis in patients refractory to steroid therapy using leached ligand fibrin stabilizing composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6029687B2 (ja) * 1978-11-07 1985-07-12 株式会社ミドリ十字 ヒト胎盤由来血液凝固第１０３因子の濃縮液の製造方法

Also Published As

Publication number Publication date
ATE83665T1 (de) 1993-01-15
KR960014789B1 (en) 1996-10-19
EP0278416A2 (de) 1988-08-17
EP0278416B1 (de) 1992-12-23
ZA88852B (en) 1988-11-30
US5378687A (en) 1995-01-03
AU1138288A (en) 1988-08-11
DK63488D0 (da) 1988-02-08
IL85346A (en) 1992-07-15
KR880009661A (ko) 1988-10-04
IE880334L (en) 1988-08-09
IE61713B1 (en) 1994-11-30
AU615428B2 (en) 1991-10-03
CA1322161C (en) 1993-09-14
PT86721B (pt) 1992-05-29
JPH0437049B2 (de) 1992-06-18
HU200277B (en) 1990-05-28
PT86721A (pt) 1988-03-01
IL85346A0 (en) 1988-07-31
HUT47221A (en) 1989-02-28
DE3876817T2 (de) 1993-05-19
ES2052614T3 (es) 1994-07-16
JPS63196520A (ja) 1988-08-15
EP0278416A3 (en) 1990-07-11
DK63488A (da) 1988-08-10
GR3007331T3 (de) 1993-07-30

Similar Documents

Publication Publication Date Title
DE69121704D1 (de) Kombinationskatheter zur beobachtung und zur dilatation von blutgefässen
DE3752045D1 (de) Verwendung von Hydroxycarbonsäuren und Derivaten zur Herstellung topischer dermatologischer Zubereitungen zur Behandlung von Falten
DE69003652D1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
DE3888064D1 (de) Niederfrequenz-Elektrotherapiegerät.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE3782498D1 (de) Verwendung von granulozyt-makrophagen-kolonie erregenden faktor zur herstellung eines medikaments zur behandlung von bakterieller krankheiten.
DE3876817D1 (de) Anwendung des humanblut-koagulationsfaktors-xiii zur behandlung von colitis gravis.
ATE83378T1 (de) Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen.
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
ATE95694T1 (de) Verwendung von bezafibrat zur behandlung von diabetes.
ATE143804T1 (de) Zusammensetzung zur behandlung von mastitis und metritis
ATE212845T1 (de) Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen
ATE81455T1 (de) (s)-emopamil zur anwendung bei der behandlung von migraene.
ATE69163T1 (de) Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen.
DE3764697D1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
DE3750248D1 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
ATE107166T1 (de) Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.
ATE216884T1 (de) Verwendung von sulbutiamin zur behandlung von psychomotorischen oder psychointellektuellen beschwerden
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
ATE63297T1 (de) Aufbereitung von fluessigkeiten und geweben mittels magnetischer induktion.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE274328T1 (de) Behandlung und fixierung von gewebe

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation